retatrutide clinical trial results 2024 2025 press release A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity | European Journal of Pharmacology Summary of the highest percent
Pay in 4 interest-free payments of $5.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22












/product/37/9787814/1.jpg?2258)















